Intelligence Platform
Patents
Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11564949
Ameliorating nervous systems disorders
granted patentUS 11566253
Targeted gene demethylation in plants
granted patentUS 11560561
Modular polypeptide libraries and methods of making and using same
granted patentUS 11559585
Conjugates of active pharmaceutical ingredients
granted patentUS 11560356
Compounds and compositions for the treatment of cancer
granted patentUS 11555057
Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor
granted patentUS 11555055
Peptide inhibitors of insulin-degrading enzyme
granted patentUS 11554180
Adeno-associated virus virions with variant capsid and methods of use thereof
granted patentUS 11549127
Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod
granted patentUS 11547663
Unit aerosol doses for anticoagulation
granted patentUS 11547674
Protein-polymer hybrid biomaterials
granted patentUS 11548953
Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment c
granted patentUS 11547664
Compositions and methods for treating eosinophilic disorders
granted patentUS 11541044
K-Ras modulators
granted patentUS 11541125
Noncrushable pill formulations
granted patentUS 11536727
Therapeutic antibodies against ROR-1 protein and methods for use of same
granted patentUS 11530421
Self-inactivating endonuclease-encoding nucleic acids and methods of using the same
granted patentUS 11530240
Catheter injectable cyclic peptide pro-gelators for myocardial tissue engineering
granted patentUS 11530259
Therapies and methods to treat TLR2-mediated diseases and disorders
granted patentUS 11530398
CRISPR-Cas effector polypeptides and methods of use thereof
granted patentUS 11524948
Prodrugs of alpha-ketoglutarate, alpha-ketobutyrate, alpha-ketoisovalerate, and alpha-keto
granted patentUS 11524053
Methods and compositions for treatment of angiogenic disorders using anti-VEGF agents
granted patentUS 11518818
Therapeutic anti-IgE antibodies and methods and compositions thereof
granted patentUS 11510929
Mitigation of epileptic seizures by combination therapy using benzodiazepines and neuroste
granted